Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Is the Risk of Preterm Birth and Low Birth Weight Affected by the Use of Antidepressant Agents during Pregnancy? A Population-Based Investigation.

Cantarutti A, Merlino L, Monzani E, Giaquinto C, Corrao G.

PLoS One. 2016 Dec 15;11(12):e0168115. doi: 10.1371/journal.pone.0168115. eCollection 2016.

2.

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.

Jordan S, Morris JK, Davies GI, Tucker D, Thayer DS, Luteijn JM, Morgan M, Garne E, Hansen AV, Klungsøyr K, Engeland A, Boyle B, Dolk H.

PLoS One. 2016 Dec 1;11(12):e0165122. doi: 10.1371/journal.pone.0165122. eCollection 2016.

4.

The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?

Daud AN, Bergman JE, Kerstjens-Frederikse WS, Groen H, Wilffert B.

Int J Mol Sci. 2016 Aug 13;17(8). pii: E1333. doi: 10.3390/ijms17081333. Review.

5.

Preschool outcomes following prenatal serotonin reuptake inhibitor exposure: differences in language and behavior, but not cognitive function.

Johnson KC, Smith AK, Stowe ZN, Newport DJ, Brennan PA.

J Clin Psychiatry. 2016 Feb;77(2):e176-82. doi: 10.4088/JCP.14m09348.

6.

Is third trimester serotonin reuptake inhibitor use associated with postpartum hemorrhage?

Kim DR, Pinheiro E, Luther JF, Eng HF, Dills JL, Wisniewski SR, Wisner KL.

J Psychiatr Res. 2016 Feb;73:79-85. doi: 10.1016/j.jpsychires.2015.11.005. Epub 2015 Nov 19.

7.

Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden.

Zoega H, Kieler H, Nørgaard M, Furu K, Valdimarsdottir U, Brandt L, Haglund B.

PLoS One. 2015 Dec 14;10(12):e0144474. doi: 10.1371/journal.pone.0144474. eCollection 2015.

8.

The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.

Salisbury AL, O'Grady KE, Battle CL, Wisner KL, Anderson GM, Stroud LR, Miller-Loncar CL, Young ME, Lester BM.

Am J Psychiatry. 2016 Feb 1;173(2):147-57. doi: 10.1176/appi.ajp.2015.14080989. Epub 2015 Oct 30.

9.

Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports.

Reefhuis J, Devine O, Friedman JM, Louik C, Honein MA; National Birth Defects Prevention Study.

BMJ. 2015 Jul 8;351:h3190. doi: 10.1136/bmj.h3190. Review.

10.

The effects of antenatal depression and antidepressant treatment on placental gene expression.

Olivier JD, Åkerud H, Skalkidou A, Kaihola H, Sundström-Poromaa I.

Front Cell Neurosci. 2015 Jan 13;8:465. doi: 10.3389/fncel.2014.00465. eCollection 2014.

11.

Early-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats.

Glover ME, Pugh PC, Jackson NL, Cohen JL, Fant AD, Akil H, Clinton SM.

Neuroscience. 2015 Jan 22;284:775-97. doi: 10.1016/j.neuroscience.2014.10.044. Epub 2014 Nov 4.

12.

Use of selective serotonin-reuptake inhibitors during pregnancy and the risk of clubfoot.

Yazdy MM, Mitchell AA, Louik C, Werler MM.

Epidemiology. 2014 Nov;25(6):859-65. doi: 10.1097/EDE.0000000000000157.

13.

Maternal Characteristics of Women Exposed to Hypnotic Benzodiazepine Receptor Agonist during Pregnancy.

Askaa B, Jimenez-Solem E, Enghusen Poulsen H, Traerup Andersen J.

Obstet Gynecol Int. 2014;2014:945621. doi: 10.1155/2014/945621. Epub 2014 Apr 10.

14.

Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay.

Harrington RA, Lee LC, Crum RM, Zimmerman AW, Hertz-Picciotto I.

Pediatrics. 2014 May;133(5):e1241-8. doi: 10.1542/peds.2013-3406. Epub 2014 Apr 14.

15.

Prenatal antidepressant exposure: clinical and preclinical findings.

Bourke CH, Stowe ZN, Owens MJ.

Pharmacol Rev. 2014 Feb 24;66(2):435-65. doi: 10.1124/pr.111.005207. Print 2014. Review.

16.

Antidepressant exposure in pregnancy and risk of autism spectrum disorders.

Sørensen MJ, Grønborg TK, Christensen J, Parner ET, Vestergaard M, Schendel D, Pedersen LH.

Clin Epidemiol. 2013 Nov 15;5:449-59. doi: 10.2147/CLEP.S53009. eCollection 2013.

17.

A "bottom-up" approach to aetiological research in autism spectrum disorders.

Unwin LM, Maybery MT, Wray JA, Whitehouse AJ.

Front Hum Neurosci. 2013 Sep 19;7:606. doi: 10.3389/fnhum.2013.00606. eCollection 2013.

18.

Antidepressant use during pregnancy: navigating the sea of information.

Einarson A.

Can Fam Physician. 2013 Sep;59(9):941, 943-4.

19.

Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study.

Jimenez-Solem E, Andersen JT, Petersen M, Broedbaek K, Andersen NL, Torp-Pedersen C, Poulsen HE.

PLoS One. 2013 Apr 25;8(4):e63034. doi: 10.1371/journal.pone.0063034. Print 2013.

20.

Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007.

Polen KN, Rasmussen SA, Riehle-Colarusso T, Reefhuis J; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2013 Jan;97(1):28-35. doi: 10.1002/bdra.23096. Epub 2012 Dec 26.

Supplemental Content

Support Center